Laboratorio Reig Jofre (RJF.MC) traded flat 0 % during a 24 hours period ending at 09:05 PM Central Europe on Monday 26th. One Laboratorio Reig Jofre stock can currently be bought for about EUR 2.55 on popular exchanges. Current supply of Laboratorio Reig Jofre stocks is 82.1 mn. Laboratorio Reig Jofre has a current market capitalization of EUR 212.6 mn and approximately EUR 8.4 k worth of Laboratorio Reig Jofre was traded on exchanges in the last 24 hours. Since last month end, Laboratorio Reig Jofre has traded 0.78 % up. Simple moving average of last 200 days is at EUR 2.65. The highest price of past 52 weeks was recorded at EUR 3 on 10/28/2025. 52 weeks low was at EUR 2.32 on 03/12/2026.

Here is how related stocks have performed in the past 24 hours:

  • Atrys Health (ATRY.MC) traded flat 0 % and now trades at EUR 2.66. Current market capitalisation for Atrys Health is EUR 198.1 mn.

  • Oryzon Genomics (ORY.MC) traded down -1.19 % and now trades at EUR 2.5. Current market capitalisation for Oryzon Genomics is EUR 204.9 mn.

  • Ecoener (ENER.MC) traded down -0.29 % and now trades at EUR 3.34. Current market capitalisation for Ecoener is EUR 192.9 mn. Ecoener has a current price to earnings ratio of 45.13.

  • Izertis (IZER.MC) traded flat 0 % and now trades at EUR 7.2. Izertis has a market capitalisation of EUR 251.9 mn. Current price/earnings ratio for Izertis is 109.24.

  • Secuoya Grupo De Comunicacio (SEC.MC) traded flat 0 % and now trades at EUR 30.4. Secuoya Grupo De Comunicacio has a market capitalisation of EUR 243.8 mn. Current price/earnings ratio for Secuoya Grupo De Comunicacio is 31.24.

About Laboratorio Reig Jofre

Laboratorio Reig Jofre SA is a pharmaceutical company based in Barcelona, Spain, that specializes in research, development, manufacturing, and marketing of pharmaceutical products and nutritional supplements. The company offers a wide range of products, including prescription medicines, over-the-counter drugs, medical devices, and cosmetics. Its product line includes technological specialization products such as antibiotics and injectable and other products; therapeutic specialization products in the areas of dermatology, respiratory/ENT, gynecology, and pediatrics; and food supplements under the Forte Pharma brand. Additionally, Laboratorio Reig Jofre SA offers research, development, and manufacturing services for pharmaceutical and biotechnology companies, as well as regulatory services; and licenses dossiers. The company sells its products directly in 7 countries and through commercial partners in approximately 65 countries on 5 continents. Laboratorio Reig Jofre SA was founded in 1929.